JobsFair.ie

Intertek employs 20 people, 95% of whom are science graduates or post graduates.

Mary O’Rourke TD has performed the official opening of the new, extended state-of-the-art pharmaceutical laboratory facility for Intertek BioClin at Monksland in Athlone. Intertek (ITRK.L), a global company listed on the London Stock Exchange, is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek is dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and over 21,000 people in 110 countries around the world. Intertek acquired the BioClin Research Laboratories in February this year from its Irish-owners. It has extended and enhanced the facilities, which continue to be locally run and managed, to increase the businesses ability to support the Irish and international pharmaceutical industry. Ireland is a key European centre for pharmaceutical manufacturing, and increasingly R&D, with many of the world's top-selling drugs being produced in Ireland. Mary O’Rourke said “Intertek’s investment in BioClin and this new, larger purpose-designed facility is excellent news for Athlone and the surrounding region. Intertek’s investment is a superb endorsement of the calibre of the services that Irish people and companies can provide to international business. "It significantly improves the range of services that the company can provide to the pharmaceutical R&D industry not just in Ireland but also internationally.” Intertek’s provides contract bio-analysis and analytical research and development, with advanced analytical services including liquid chromatography-tandem mass spectrometry (LC/MS/MS) to the local and international pharmaceutical, biopharmaceutical and medical device industries. At 9,500 sq ft it is around 40% larger than the original 6,000 sq ft facility operated in Athlone for the past five years. It employs 20 people, 95% of whom are science graduates or post graduates. Intertek continues to grow its global support and services to the pharmaceutical sector through recent acquisitions and investment in organic growth in this sector internationally. Wolfhart Hauser, Intertek’s CEO, said “Intertek is pleased to grow our support to our global pharmaceutical clients and pharmaceutical industry in Ireland. As Intertek’s first significant laboratory in Ireland, we are pleased to bring the reach of our global network of quality and safety services and laboratories to Irish business looking to trade globally and support business growth in Athlone and greater Ireland”.